OBJECTIVE: This study aimed at investigating the prevalence, psychiatric comorbidity and outpatient treatment in a sample of German children and adolescents with eating disorders (EDs). METHOD: Data of a large German statutory health insurance company were analysed and outpatients aged between 10 and 21 years with an ED diagnosis in 2009 were identified. RESULTS: Of 248,558 insured children and adolescents, 1,404 patients (79.9 % females, mean age: 16.7; SD: 3.3 years) matched the inclusion criteria. The large majority of patients with anorexia nervosa (AN) and bulimia nervosa (BN) were females (94.7 and 92.7 %), on which we focus in the following analyses. The prevalence in females was 0.28 % (AN) and 0.20 % (BN). Psychiatric comorbidity was diagnosed in 59.8 % (AN) and 64.1 % (BN) of patients, respectively. Most patients were treated with psychotherapy (AN: 75.7 %, BN: 78.5 %), 16.4 % (AN) and 20.2 % (BN) of our patients received pharmacotherapy with either antidepressants or antipsychotics. 23.5 % (AN) and 21.1 % (BN) received no treatment with psychotherapy, antidepressants or antipsychotics. DISCUSSION: This naturalistic study suggests that in young ED outpatients, EDs seem to be underdiagnosed and treatment does not necessarily comply with current guidelines. Therefore, dissemination of state-of-the-art knowledge on diagnosis and treatment in children and adolescents with EDs constitutes an important educational goal.
OBJECTIVE: This study aimed at investigating the prevalence, psychiatric comorbidity and outpatient treatment in a sample of German children and adolescents with eating disorders (EDs). METHOD: Data of a large German statutory health insurance company were analysed and outpatients aged between 10 and 21 years with an ED diagnosis in 2009 were identified. RESULTS: Of 248,558 insured children and adolescents, 1,404 patients (79.9 % females, mean age: 16.7; SD: 3.3 years) matched the inclusion criteria. The large majority of patients with anorexia nervosa (AN) and bulimia nervosa (BN) were females (94.7 and 92.7 %), on which we focus in the following analyses. The prevalence in females was 0.28 % (AN) and 0.20 % (BN). Psychiatric comorbidity was diagnosed in 59.8 % (AN) and 64.1 % (BN) of patients, respectively. Most patients were treated with psychotherapy (AN: 75.7 %, BN: 78.5 %), 16.4 % (AN) and 20.2 % (BN) of our patients received pharmacotherapy with either antidepressants or antipsychotics. 23.5 % (AN) and 21.1 % (BN) received no treatment with psychotherapy, antidepressants or antipsychotics. DISCUSSION: This naturalistic study suggests that in young ED outpatients, EDs seem to be underdiagnosed and treatment does not necessarily comply with current guidelines. Therefore, dissemination of state-of-the-art knowledge on diagnosis and treatment in children and adolescents with EDs constitutes an important educational goal.
Authors: Laura Haas; Tom Stargardt; Jonas Schreyoegg; Rico Schlösser; Gerhard Danzer; Burghard F Klapp Journal: Int J Eat Disord Date: 2011-03-03 Impact factor: 4.861
Authors: N T Godart; F Perdereau; F Curt; F Lang; J L Venisse; O Halfon; P Bizouard; G Loas; M Corcos; Ph Jeammet; M F Flament Journal: Eat Weight Disord Date: 2004-12 Impact factor: 4.652
Authors: Jennifer Hagman; Jane Gralla; Eric Sigel; Swan Ellert; Mindy Dodge; Rick Gardner; Teri O'Lonergan; Guido Frank; Marianne Z Wamboldt Journal: J Am Acad Child Adolesc Psychiatry Date: 2011-08-05 Impact factor: 8.829
Authors: Christopher G Fairburn; Zafra Cooper; Kristin Bohn; Marianne E O'Connor; Helen A Doll; Robert L Palmer Journal: Behav Res Ther Date: 2007-02-04
Authors: Cynthia M Bulik; Laura Thornton; Andréa Poyastro Pinheiro; Katherine Plotnicov; Kelly L Klump; Harry Brandt; Steve Crawford; Manfred M Fichter; Katherine A Halmi; Craig Johnson; Allan S Kaplan; James Mitchell; Detlev Nutzinger; Michael Strober; Janet Treasure; D Blake Woodside; Wade H Berrettini; Walter H Kaye Journal: Psychosom Med Date: 2008-02-06 Impact factor: 4.312
Authors: Lisa Feldmann; Ellen Greimel; Carolin Zsigo; Anca Sfärlea; Carolin Lingl; Charlotte Piechaczek; Gerd Schulte-Körne Journal: Child Psychiatry Hum Dev Date: 2022-04-12
Authors: Anna Svedlund; Cecilia Pettersson; Bojan Tubic; Lars Ellegård; Anders Elfvin; Per Magnusson; Diana Swolin-Eide Journal: J Bone Miner Metab Date: 2022-08-12 Impact factor: 2.976